InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,917.20
(
0.36%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.42
(
-1.26%
)
Bitcoin
56,649.87
(
1.44%
)
Post# of 252524
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: mcbio post# 193953

Friday, 07/31/2015 4:18:05 AM

Friday, July 31, 2015 4:18:05 AM

Post# of 252524
GLPG:

On IPF I thought along the line they said it was a portfolio decision (Not sure going by memory don't have notes saying as such) but I could be mixing it up with one of their other programs. They've had no shortage of setbacks in their early stage development!

On Crohn's Think JAK1 is involved in process and the company said they will present more supportive data in august. Also think being JAK2 sparing will help patients recover quickly since they have low level of red blood cells.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up